These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 18756939)
1. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening]. Xu T; Lu HJ; He YF Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939 [TBL] [Abstract][Full Text] [Related]
2. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728 [TBL] [Abstract][Full Text] [Related]
3. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832 [TBL] [Abstract][Full Text] [Related]
4. [The usefulness of p16INK4a in cytological screening of cervical carcinoma]. Li M; Cao J; Wang NP; Li LY; Li L; Qiao YL; Pan QJ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):674-7. PubMed ID: 17274373 [TBL] [Abstract][Full Text] [Related]
5. [Clinical value of p16 Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350 [No Abstract] [Full Text] [Related]
6. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear. Bose S; Evans H; Lantzy L; Scharre K; Youssef E Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047 [TBL] [Abstract][Full Text] [Related]
7. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891 [TBL] [Abstract][Full Text] [Related]
8. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions]. Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269 [TBL] [Abstract][Full Text] [Related]
9. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia. Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067 [TBL] [Abstract][Full Text] [Related]
11. The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears. Sung CO; Kim SR; Oh YL; Song SY Diagn Cytopathol; 2010 Mar; 38(3):168-71. PubMed ID: 19760769 [TBL] [Abstract][Full Text] [Related]
12. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296 [TBL] [Abstract][Full Text] [Related]
13. [Application of high-risk human papillomavirus testing in women with abnormal cytology]. Ou H; Bian ML; Zhang XY; Chen QY; Li M; Chen Y; Liu J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714 [TBL] [Abstract][Full Text] [Related]
14. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion]. Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618 [TBL] [Abstract][Full Text] [Related]
15. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China. Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia. Holladay EB; Logan S; Arnold J; Knesel B; Smith GD Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096 [TBL] [Abstract][Full Text] [Related]
17. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia]. Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection. Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898 [TBL] [Abstract][Full Text] [Related]
19. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920 [TBL] [Abstract][Full Text] [Related]
20. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA. Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]